Why Are Evelo Biosciences Stock Is Trading Higher Today?

Evelo Biosciences Inc EVLO shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc BIO.

The agreement, originally established on December 27, 2017, has ended. As a result of this termination, Evelo Biosciences has agreed to make a termination payment of $523,556 to Bio-Rad. 

Additionally, they have granted Bio-Rad the authority to draw on a letter of credit amounting to $850,000.

It is worth noting that this termination also presents the possibility of an additional payment of up to $2.5 million, further emphasizing the financial implications of this move. 

Price Action: EVLO shares are up 27.50% at $12.57 on the last check Friday. BIO shares are up 1.35% at $403.60 on the last check Friday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareMoversGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!